加加食品(002650.SZ):擬推不超4650萬份股票期權激勵計劃
格隆匯10月22日丨加加食品(002650.SZ)披露2021年股票期權激勵計劃(草案)。該激勵計劃股票來源為公司向激勵對象定向發行的公司人民幣A股普通股股票。激勵對象不包括按規定不能成為激勵對象的獨立董事、監事及單獨或合計持有上市公司5%以上股份的股東或實際控制人及其配偶、父母、子女。
該激勵計劃擬向激勵對象授予權益總計不超過4650萬份,約佔該計劃公吿時公司股本總額的4.04%,預留授予929萬份,約佔該激勵計劃草案公吿時公司股本總額的0.81%。該激勵計劃首次和預留授予的股票期權的行權價格為每股4.95元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.